Search research articles
Contact Us
Filters
Showing results (401-410 of 422) with videos related to
Page
of 43
Sort By:
Blood
|
April 17, 2013
The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial
Peter W Hunt, Nancy S Shulman, Timothy L Hayes, et al.
Pediatric Blood & Cancer
|
July 21, 2020
The use of interval-compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumor
Kevin X Liu, Natalie B Collins, Katie A Greenzang, et al.
Gastroenterology
|
July 2, 2013
Randomized controlled trial of danoprevir plus peginterferon alfa-2a and ribavirin in treatment-naïve patients with hepatitis C virus genotype 1 infection
Patrick Marcellin, Curtis Cooper, Luis Balart, et al.
Translational Oncology
|
June 18, 2026
Combined inhibition of CDK4/6 and PI3K pathways exhibit highly synergistic activity and translational potential in Ewing sarcoma
Helen F Gloege, Maria Ana Isabel C De Los Santos, Advaita Chakraborty, et al.
Cancer
|
July 2, 2026
Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study
Duncan C Ramsey, David S Shulman, Grace C Zhou, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
Molecular characterization informs prognosis in patients with localized Ewing sarcoma: A report from the Children's Oncology Group
Riaz Gillani, David S Shulman, Natalie J DelRocco, et al.
Open Forum Infectious Diseases
|
September 27, 2017
Safety and Efficacy of Ombitasvir, Paritaprevir With Ritonavir ± Dasabuvir With or Without Ribavirin in Patients With Human Immunodeficiency Virus-1 and Hepatitis C Virus Genotype 1 or Genotype 4 Coinfection: TURQUOISE-I Part 2
Jürgen K Rockstroh, Chloe Orkin, Rolando M Viani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 23, 2018
Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study
Jürgen K Rockstroh, Karine Lacombe, Rolando M Viani, et al.
Hepatology (Baltimore, Md.)
|
April 20, 2018
Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection
Nancy Reau, Paul Y Kwo, Susan Rhee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 3, 2025
Molecular Characterization Informs Prognosis in Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group
Riaz Gillani, David S Shulman, Natalie J DelRocco, et al.
Page
of 43
Search research articles
Search
Showing results (401-410 of 422) with videos related to
Sort By:
Page
of 43
Blood
|
April 17, 2013
The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial
Peter W Hunt, Nancy S Shulman, Timothy L Hayes, et al.
Pediatric Blood & Cancer
|
July 21, 2020
The use of interval-compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumor
Kevin X Liu, Natalie B Collins, Katie A Greenzang, et al.
Gastroenterology
|
July 2, 2013
Randomized controlled trial of danoprevir plus peginterferon alfa-2a and ribavirin in treatment-naïve patients with hepatitis C virus genotype 1 infection
Patrick Marcellin, Curtis Cooper, Luis Balart, et al.
Translational Oncology
|
June 18, 2026
Combined inhibition of CDK4/6 and PI3K pathways exhibit highly synergistic activity and translational potential in Ewing sarcoma
Helen F Gloege, Maria Ana Isabel C De Los Santos, Advaita Chakraborty, et al.
Cancer
|
July 2, 2026
Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study
Duncan C Ramsey, David S Shulman, Grace C Zhou, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
Molecular characterization informs prognosis in patients with localized Ewing sarcoma: A report from the Children's Oncology Group
Riaz Gillani, David S Shulman, Natalie J DelRocco, et al.
Open Forum Infectious Diseases
|
September 27, 2017
Safety and Efficacy of Ombitasvir, Paritaprevir With Ritonavir ± Dasabuvir With or Without Ribavirin in Patients With Human Immunodeficiency Virus-1 and Hepatitis C Virus Genotype 1 or Genotype 4 Coinfection: TURQUOISE-I Part 2
Jürgen K Rockstroh, Chloe Orkin, Rolando M Viani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 23, 2018
Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study
Jürgen K Rockstroh, Karine Lacombe, Rolando M Viani, et al.
Hepatology (Baltimore, Md.)
|
April 20, 2018
Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection
Nancy Reau, Paul Y Kwo, Susan Rhee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 3, 2025
Molecular Characterization Informs Prognosis in Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group
Riaz Gillani, David S Shulman, Natalie J DelRocco, et al.
Page
of 43